feed,title,long_url,short_url
Motley,Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.,https://www.fool.com/investing/2025/12/12/pfizer-is-struggling-to-replace-its-covid-revenue/?source=iedfolrf0000001,
